Drug Patent Expirations for the Week of July 30, 2023

DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirati…


New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR

Annual Drug Patent Expirations for KOMBIGLYZE+XR Kombiglyze Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR app…


Biotechblog